THYROCARENSEThyrocare Technologies LimitedMediumNeutral
Announced Tue, 30 Jun · 20:57 IST

Thyrocare shareholders approve MOA amendment at AGM

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.4%1-day move
₹549.20
prior close
₹554.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3-0.4-0.6-1.5+1.4+0.9-1.1-3.1-4.6-6.1+1.6
Up moveDown movePending
AI summary

At Thyrocare's 26th AGM on June 30, 2026, shareholders approved amendments to the Memorandum of Association (MOA). The main change adds a new sub-clause 1B that broadens the company's permitted business scope to include diagnostic facilities, hospitals, clinics, radiology, pathology centres, digital healthcare platforms, medical devices and equipment, and related services in India and abroad. Other changes replace Companies Act 1956 references with the 2013 Act, delete the 'Other Objects' clause, and update liability language. This is a corporate housekeeping and scope-expansion update.

Likely market impact

Broadens business scope to digital health and medical devices; largely a governance update with no immediate financial impact.